Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minoru Fukuchi

Showing results (171-180 of 173) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 173 results.
Hepato-Gastroenterology|December 13, 2005
Clinical factors influencing CT findings in patients with acute appendicitisKatsuhiko Tsukada, Tatsuya Miyazaki, Hiroyuki Katoh, et al.
Anticancer Research|August 19, 2007
Prediction of response to definitive chemoradiotherapy in esophageal cancer using positron emission tomographyHiroyuki Kato, Minoru Fukuchi, Tatsuya Miyazaki, et al.
Oncology Letters|February 14, 2018
High expression of carcinoembryonic antigen and telomerase reverse transcriptase in circulating tumor cells is associated with poor clinical response to the immune checkpoint inhibitor nivolumabHalin Bao, Tuya Bai, Koji Takata, et al.
Pageof 18

Showing results (171-180 of 173) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 173 results.
Hepato-Gastroenterology|December 13, 2005
Clinical factors influencing CT findings in patients with acute appendicitisKatsuhiko Tsukada, Tatsuya Miyazaki, Hiroyuki Katoh, et al.
Anticancer Research|August 19, 2007
Prediction of response to definitive chemoradiotherapy in esophageal cancer using positron emission tomographyHiroyuki Kato, Minoru Fukuchi, Tatsuya Miyazaki, et al.
Oncology Letters|February 14, 2018
High expression of carcinoembryonic antigen and telomerase reverse transcriptase in circulating tumor cells is associated with poor clinical response to the immune checkpoint inhibitor nivolumabHalin Bao, Tuya Bai, Koji Takata, et al.
Pageof 18